Ionis Pharmaceuticals Inc

NASDAQ:IONS 4:00:00 PM EDT

40.91

-0.63 (-1.52%)

5:28:22 PM EDT: $40.74 -0.17 (-0.42%)

Market Cap (Intraday)	5.96B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$144.89 Million
Adjusted EPS	-$1.01

See more estimates

10-Day MA	$41.87
50-Day MA	$44.31
200-Day MA	$45.39

See more pivots

Ionis Pharmaceuticals Inc Stock, NASDAQ:IONS

2855 Gazelle Court, Carlsbad, California 92010

United States of America

Phone: +1.760.931.9200

Number of Employees: 927

http://www.ionispharm.com

Description

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.